Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Schultz

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Clinical Biochemistry|June 7, 2020
Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancerLine J H Rasmussen, Martin Schultz, Kasper Iversen, et al.
World Journal of Surgery|November 4, 2018
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk AssessmentsMorten Alstrup, Jeppe Meyer, Martin Schultz, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|August 6, 2016
Introduction of a prognostic biomarker to strengthen risk stratification of acutely admitted patients: rationale and design of the TRIAGE III cluster randomized interventional trialAndreas Sandø, Martin Schultz, Jesper Eugen-Olsen, et al.
Danish Medical Journal|September 25, 2024
Profile of the acutely admitted geriatric patientRikke S Kamper, Hanne Nygaard, Martin Schultz, et al.
British Journal of Cancer|April 8, 2021
The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)Cecilia Margareta Lund, Kirsten Kjeldgaard Vistisen, Anne Pries Olsen, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 19, 2024
GDF-15 is associated with sarcopenia and frailty in acutely admitted older medical patientsRikke S Kamper, Hanne Nygaard, Louis Praeger-Jahnsen, et al.
Ugeskrift for Laeger|October 18, 2018
[Review of Early Warning Score in preventing sudden critical illness and death]Pernille Brok Nielsen, Niels Engholm Pedersen, Martin Schultz, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|April 13, 2019
Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trialMartin Schultz, Line J H Rasmussen, Thomas Kallemose, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 20, 2022
Predictive and prognostic value of different cardiac troponin assays: a nationwide register-based cohort studyRasmus B Hasselbalch, Martin Schultz, Philip A Schytz, et al.
BMC Geriatrics|May 18, 2019
Risk assessment models for potential use in the emergency department have lower predictive ability in older patients compared to the middle-aged for short-term mortality - a retrospective cohort studyMartin Schultz, Line Jee Hartmann Rasmussen, Nicolas Carlson, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Clinical Biochemistry|June 7, 2020
Soluble urokinase plasminogen activator receptor (suPAR) is lower in disease-free patients but cannot rule out incident disease in patients with suspected cancerLine J H Rasmussen, Martin Schultz, Kasper Iversen, et al.
World Journal of Surgery|November 4, 2018
Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk AssessmentsMorten Alstrup, Jeppe Meyer, Martin Schultz, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|August 6, 2016
Introduction of a prognostic biomarker to strengthen risk stratification of acutely admitted patients: rationale and design of the TRIAGE III cluster randomized interventional trialAndreas Sandø, Martin Schultz, Jesper Eugen-Olsen, et al.
Danish Medical Journal|September 25, 2024
Profile of the acutely admitted geriatric patientRikke S Kamper, Hanne Nygaard, Martin Schultz, et al.
British Journal of Cancer|April 8, 2021
The effect of geriatric intervention in frail older patients receiving chemotherapy for colorectal cancer: a randomised trial (GERICO)Cecilia Margareta Lund, Kirsten Kjeldgaard Vistisen, Anne Pries Olsen, et al.
Journal of Cachexia, Sarcopenia and Muscle|June 19, 2024
GDF-15 is associated with sarcopenia and frailty in acutely admitted older medical patientsRikke S Kamper, Hanne Nygaard, Louis Praeger-Jahnsen, et al.
Ugeskrift for Laeger|October 18, 2018
[Review of Early Warning Score in preventing sudden critical illness and death]Pernille Brok Nielsen, Niels Engholm Pedersen, Martin Schultz, et al.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine|April 13, 2019
Availability of suPAR in emergency departments may improve risk stratification: a secondary analysis of the TRIAGE III trialMartin Schultz, Line J H Rasmussen, Thomas Kallemose, et al.
European Heart Journal. Quality of Care & Clinical Outcomes|October 20, 2022
Predictive and prognostic value of different cardiac troponin assays: a nationwide register-based cohort studyRasmus B Hasselbalch, Martin Schultz, Philip A Schytz, et al.
BMC Geriatrics|May 18, 2019
Risk assessment models for potential use in the emergency department have lower predictive ability in older patients compared to the middle-aged for short-term mortality - a retrospective cohort studyMartin Schultz, Line Jee Hartmann Rasmussen, Nicolas Carlson, et al.
Pageof 8